Trial Profile
Hydrochloride granisetron transdermal patches, hydrochloride granisetron tablets and Sancuso transdermal patches pharmacokinetic characteristics and security in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs Granisetron (Primary) ; Granisetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Pharmacokinetics
- 22 Jan 2013 New trial record